6 episodes

Ori Spotlight covers the latest in cell and gene therapy.

Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments.

Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect

Ori Spotlight Ori Biotech

    • Science

Ori Spotlight covers the latest in cell and gene therapy.

Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments.

Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while increasing throughput and improving quality: www.oribiotech.com/connect

    Dennis Powers - Vice President of Business Development & Sales Engineering, G-CON Manufacturing

    Dennis Powers - Vice President of Business Development & Sales Engineering, G-CON Manufacturing

    Dennis Powers, Vice President of Business Development & Sales Engineering at G-CON Manufacturing joins Jason C. Foster for the new episode of the Ori Spotlight Podcast.  

    Dennis explains how manufacturing powerhouse G-CON is injecting innovation right into the heart of cell and gene therapy with their prefabricated cleanrooms called PODs. 

    Drawing on his wealth of experience in life sciences and biotech, Dennis also shares his predictions for the manufacturing industry from his unique vantage point.

    Learn more about Dennis Powers | 

    Learn more about Ori Biotech | www.oribiotech.com

    • 45 min
    Rahul Singhvi - Co-founder and CEO, Resilience

    Rahul Singhvi - Co-founder and CEO, Resilience

    Rahul Singhvi, Co-Founder and CEO at Resilience joins Jason C. Foster for the new episode of the Ori Spotlight Podcast.  With extensive experience leading vaccine technologies and biotherapeutics at Merck and Takeda, Rahul co-founded Resilience in order to create the next generation of life science manufacturing, to meet the urgent need at what is an inflection point for the biotechnology industry.

    Learn more about Resilience | www.resilience.com

    Learn more about Ori Biotech | www.oribiotech.com

    • 51 min
    Deanna M. Petersen - Chief Business Officer, AVROBIO

    Deanna M. Petersen - Chief Business Officer, AVROBIO

    Deanna M. Petersen, Chief Business Officer at AVROBIO joins Jason C. Foster on the new episode of Ori Spotlight. 

    Having led mergers and acquisitions for with some of the biggest names in biotech including Shire's $4.2 billion acquisition of ViroPharma, Deanna is unquestionably a powerhouse leader in the space. 

    Now, as the 4th employee at AVROBIO, she talks about how she built a pipeline of personalized gene therapies and some of the challenges she faced. The biggest? Chemistry, Manufacturing and Controls (CMCs).

    Learn more about Deanna M. Petersen | www.linkedin.com/in/dmpetersen

    Learn more about Ori Biotech | www.oribiotech.com 

    • 38 min
    Bruce Levine PHD - Professor in Cancer Gene Therapy, University of Pennsylvania

    Bruce Levine PHD - Professor in Cancer Gene Therapy, University of Pennsylvania

    For episode three of Ori Spotlight, Bruce Levine, PhD., Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania Perelman School of Medicine and current President of International Society for Cell and Gene Therapy (ISCT) joins our host Jason C. Foster. 

    Professor Levine pioneered the very first FDA approved CAR-T therapy Kymriah®and is a driving force across the cell and gene therapy industry, holding numerous positions at some of the most progressive CGT institutions in the world. 

    In this episode he shares his perspectives on the industry shift that is needed to enable widespread access to these life-saving treatments and the responsibility of all stakeholders to make it happen.

    Learn more about Ori Biotech: www.oribiotech.com | 
    Learn more about Professor Bruce Levine | 

    • 39 min
    Tom & Emily Whitehead with Vincent Carrano - Emily Whitehead Foundation

    Tom & Emily Whitehead with Vincent Carrano - Emily Whitehead Foundation

    In this episode of Ori Spotlight, Jason C. Foster is joined by Tom and Emily Whitehead, along with Vincent Carrano, Director of Development and Engagement at the Emily Whitehead Foundation.

    The Emily Whitehead Foundation is on a mission to make promising research and therapies, including CAR T-cell therapy, as well other immunotherapies more accessible to all patients.

    Together we discuss Emily’s journey as the first child to take part in a T-cell trial, as well as the access challenges for patients in need of innovative cell and gene therapies.

    Order The Whitehead Family's new book | ‘Praying for Emily’

    Connect with Ori Biotech | www.oribiotech.com/connect 

    Learn more about the Emily Whitehead Foundation | www.emilywhiteheadfoundation.org

    • 43 min
    Anthony Davies - Founder & CEO, Dark Horse Consulting

    Anthony Davies - Founder & CEO, Dark Horse Consulting

    On this week’s episode of Ori Spotlight, Jason C. Foster is joined by Anthony Davies, Founder and CEO of Dark Horse Consulting. 

    Anthony has spent more than 20 years sharing his leadership experience in product, process and manufacturing development to cell and gene therapy (CGT) companies in need. 

    We discuss some of the most significant barriers to innovation and scale in CGT and how they impact patients.

    Learn more about Ori Biotech: www.oribiotech.com | info@oribiotech.com

    Learn more about Dark Horse Consulting: https://darkhorseconsultinggroup.com

    • 43 min

Top Podcasts In Science